Sanjeev Vashishta, chief executive officer at SRL Diagnostics, talks to Deepak Patel about expansion plans and regulations for the sector.
Govt bans brands with annual sales worth Rs 3,728 crore.
It should be noted that the CPC allocation is provisional.
Between 2011 and 2014, they indirectly determined the price of tyres in the market, says report
Lobby group tells USTR it has got assurance from India on compulsory licensing.
A dialysis machine contributes only 6 per cent to the overall cost.
The panel's recommendations will be aimed at making a predictable and non-adversarial tax regime in the economy.
Budget may bring exemption for those backed by Indian securities other than shares
Changes in threshold not to have a significant revenue impact, say officials
This move to make it easier for funds to avail of tax exemptions.
11 states were assessed for access to clean water, energy and sanitation and use of iodised salt.
The impact from NELM on the Indian pharmaceutical sector is estimated to be around Rs 6,000 crore.
Chief economic advisor Arvind Subramanian discusses the Budget, goods and services tax, Centre-state relationship and larger issues facing the economy
An announcement has barred the entry of journalists in the finance ministry.
The French drug maker has its vaccine approved in Mexico for all four serotypes for patients aged 9 to 45.
The BSE fined 370 listed companies following the Sebi notification.
'We need to do more to accelerate growth.'
Experts have started giving comments on provisions that the govt must make in Budget 2016-17.
Even today, many MFIs already distribute pension and micro insurance products to low-income households.
Workers' attitude is changing and they want to work more and demand more wages. They want more productivity.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances